Clinical trial
Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates
NCT00203775 · University of Connecticut, Other · Terminated
Key facts
| NCT number | NCT00203775 |
|---|---|
| Title | Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates |
| Official title | Efficacy of Risperidone Versus Haloperidol in the Treatment of Aggression and Hostility in Psychotic Inmates |
| Lead sponsor | University of Connecticut, Other |
| Collaborators | Janssen Pharmaceutica N.V., Belgium Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Psychosis, Aggression |
| Intervention type | Drug |
| Interventions | risperidone |
| Start date | Jul 1, 2002 |
| Completion | Apr 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 13, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: